相似文献
1
The role of NAFLD in cardiometabolic disease: an update.
F1000Res. 2018 Feb 9;7:170. doi: 10.12688/f1000research.12028.1. eCollection 2018.
2
The Natural Course of Non-Alcoholic Fatty Liver Disease.
Int J Mol Sci. 2016 May 20;17(5):774. doi: 10.3390/ijms17050774.
3
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.
World J Gastroenterol. 2015 Jun 14;21(22):6820-34. doi: 10.3748/wjg.v21.i22.6820.
4
NAFLD: a multisystem disease.
J Hepatol. 2015 Apr;62(1 Suppl):S47-64. doi: 10.1016/j.jhep.2014.12.012.
5
[Non-alcoholic fatty liver disease--new view].
Pol Merkur Lekarski. 2008 Jun;24(144):568-71.
6
Ectopic fat, insulin resistance and non-alcoholic fatty liver disease.
Proc Nutr Soc. 2013 Nov;72(4):412-9. doi: 10.1017/S0029665113001249. Epub 2013 May 14.
7
Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases.
Diabetes Metab J. 2017 Dec;41(6):430-437. doi: 10.4093/dmj.2017.41.6.430. Epub 2017 Nov 17.
8
Non-alcoholic fatty liver disease from pathogenesis to management: an update.
Obes Rev. 2010 Jun;11(6):430-45. doi: 10.1111/j.1467-789X.2009.00657.x. Epub 2009 Oct 21.
9
Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis.
Eur J Pediatr. 2017 Apr;176(4):529-536. doi: 10.1007/s00431-017-2876-1. Epub 2017 Feb 17.
10
[Pediatric non-alcoholic fatty liver disease: recent advances and challenges].
Minerva Pediatr. 2010 Dec;62(6):569-84.
引用本文的文献
1
Integrating liver and heart health: Cardiovascular risk reduction in patients with metabolic-associated steatotic liver disease.
World J Cardiol. 2025 Jul 26;17(7):107751. doi: 10.4330/wjc.v17.i7.107751.
2
Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis.
Curr Cardiol Rep. 2025 Jan 18;27(1):28. doi: 10.1007/s11886-024-02185-5.
3
Non-alcoholic fatty liver modifies associations of body mass index and waist circumference with cardiometabolic risk: The CARDIA study.
Obes Sci Pract. 2024 Apr 23;10(2):e751. doi: 10.1002/osp4.751. eCollection 2024 Apr.
4
Fasting Plasma Ketone Bodies Are Associated with NT-proBNP: A Potential Mechanism to Provide Fuel for the Failing Heart.
J Clin Med. 2024 Mar 7;13(6):1541. doi: 10.3390/jcm13061541.
5
Aerobic and Muscle-Strengthening Physical Activity, Television Viewing, and Nonalcoholic Fatty Liver Disease: The CARDIA Study.
J Clin Med. 2023 Aug 28;12(17):5603. doi: 10.3390/jcm12175603.
6
Heart Uptake of [F]Fluoro-4-Thia-Oleate in a Non-Alcoholic Fatty Liver Disease Mouse Model.
Pharmaceuticals (Basel). 2022 Dec 17;15(12):1577. doi: 10.3390/ph15121577.
7
Effects of serum branched-chain amino acids on nonalcoholic fatty liver disease and subsequent cardiovascular disease.
Hepatol Int. 2022 Dec;16(6):1424-1434. doi: 10.1007/s12072-022-10387-8. Epub 2022 Jul 18.
8
Nonalcoholic fatty liver disease, circulating ketone bodies and all-cause mortality in a general population-based cohort.
Eur J Clin Invest. 2021 Dec;51(12):e13627. doi: 10.1111/eci.13627. Epub 2021 Jun 13.
9
Mechanisms of Action of trans Fatty Acids.
Adv Nutr. 2020 May 1;11(3):697-708. doi: 10.1093/advances/nmz125.
10
Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression.
Cells. 2019 Oct 30;8(11):1358. doi: 10.3390/cells8111358.
本文引用的文献
1
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance.
Hepatology. 2018 Jan;67(1):145-158. doi: 10.1002/hep.29465. Epub 2017 Nov 17.
2
Additive effect of non-alcoholic fatty liver disease on the development of diabetes in individuals with metabolic syndrome.
Diabetes Res Clin Pract. 2017 Jul;129:136-143. doi: 10.1016/j.diabres.2017.03.037. Epub 2017 May 5.
3
Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals.
Endocrine. 2017 Jul;57(1):89-97. doi: 10.1007/s12020-017-1313-6. Epub 2017 May 16.
4
The Correlation Between Body Fat, Visceral Fat, and Nonalcoholic Fatty Liver Disease.
Metab Syndr Relat Disord. 2017 Aug;15(6):304-311. doi: 10.1089/met.2017.0001. Epub 2017 May 8.
5
Natural History of NAFLD Diagnosed in Childhood: A Single-Center Study.
Children (Basel). 2017 May 3;4(5):34. doi: 10.3390/children4050034.
6
Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci.
Nat Genet. 2017 Jun;49(6):842-847. doi: 10.1038/ng.3855. Epub 2017 Apr 24.
7
Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children.
J Pediatr. 2017 Aug;187:141-146.e1. doi: 10.1016/j.jpeds.2017.03.007. Epub 2017 Mar 30.
8
Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.
Gut. 2017 Jun;66(6):1138-1153. doi: 10.1136/gutjnl-2017-313884. Epub 2017 Mar 17.
9
Adolescent Obesity and Insulin Resistance: Roles of Ectopic Fat Accumulation and Adipose Inflammation.
Gastroenterology. 2017 May;152(7):1638-1646. doi: 10.1053/j.gastro.2016.12.051. Epub 2017 Feb 10.
10
Visceral fat is associated with the racial differences in liver fat between black and white adolescent boys with obesity.
Pediatr Diabetes. 2017 Nov;18(7):660-663. doi: 10.1111/pedi.12492. Epub 2017 Feb 8.
Zotero 插件